Article
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer
21 Jan 2023
Abstract excerpt
BACKGROUND: Current diagnosis tools for prostate cancer (PCa) such as serum PSA detection and prostate biopsy cannot distinguish dormant tumors from invasive malignancies, either be used as prognosis marker for castration resistant prostate cancer (CRPC), the lethal stage of PCa patients. Exosomes have been widely investigated as promising biomarkers for various diseases. We aim to characterize the proteomic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
